Swedish Orphan Biovitrum ^Company

Swedish Orphan Biovitrum AG is an integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. The company offers drugs for the treatment of rare and life-threatening diseases, such as cardiology, diseases affecting immunocompromised patients, genetic disorders, hematology, infectious diseases, etc.